SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-045798
Filing Date
2021-08-26
Accepted
2021-08-25 21:41:18
Documents
85
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q emma-10q_20200930.htm   iXBRL 10-Q 3433853
2 EX-10.1 emma-ex101_6.htm EX-10.1 43015
3 EX-31.1 emma-ex311_8.htm EX-31.1 9934
4 EX-31.2 emma-ex312_9.htm EX-31.2 10012
5 EX-32.1 emma-ex321_7.htm EX-32.1 7816
  Complete submission text file 0001564590-21-045798.txt   15726785

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA emma-20200930.xsd EX-101.SCH 84811
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE emma-20200930_cal.xml EX-101.CAL 77433
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE emma-20200930_def.xml EX-101.DEF 332049
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE emma-20200930_lab.xml EX-101.LAB 624047
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE emma-20200930_pre.xml EX-101.PRE 521092
11 EXTRACTED XBRL INSTANCE DOCUMENT emma-10q_20200930_htm.xml XML 4105596
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35527 | Film No.: 211208620
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences